Immunohistochemistry is a technique for localizing and visualizing an antigen in a tissue section by using an antibody specific for the target antigen. We at HRL offer a wide spectrum of Immuno Stains as listed below.
|
Stain Name
|
Application
|
Image
|
|
CD3
|
lymphoma leukemia typing
|
|
|
CD5
|
lymphoma leukemia typing
|
|
|
CD10
|
leukemia typing metastatic carcinoma unknown primary
|
|
|
CD20
|
lymphoma
leukemia typing
|
|
|
CD30
|
lymphoma typing
|
|
|
CD34
|
soft tissue tumor classification leukemia typing
|
|
|
CD56
|
lymphoma typing
neuroendocrine differentiation
|
|
|
Cytokeratin 7
|
metastatic carcinoma unknown primary
|
|
|
Cytokeratin 20
|
metastatic carcinoma unknown primary
|
|
|
AE1 Keratin
|
metastatic carcinoma unknown primary
|
|
|
AE3 Keratin
|
carcinomas vs non epithelial tumors
|
|
|
Pan Keratin
|
normal vs abnormal epithelial cells
|
|
|
PIN4
|
triple stain
prostate carcinoma in needle biopsy
|
|
|
Actin
|
muscle vs myofibroblastic differentiation
|
|
|
Cal Ret
|
mesothelioma, adrenal, stromal tumors
|
|
|
CEA
|
metastatic carcinoma unknown primary
|
|
|
Chromogranin
|
neuroendocrine differentiation
|
|
|
E-Cad
|
lobular vs ductal breast carcinoma
|
|
|
MART-1
|
melanoma
|
|
|
LCA
|
most t-cell lymphomas, some b-cell lymphomas
|
|
|
S-100
|
melanoma, neural marker
|
|
|
Synap
|
neuroendocrine differentiation
|
|
|
TTF1
|
lung & thyroid marker
|
|
|
Vimentin
|
metastatic carcinoma unknown primary
|
|
